Cyclodextrin-Modified Nanomaterials for Drug Delivery and Biomedical Applications: Theoretical and Experimental Studies

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".

Deadline for manuscript submissions: 20 December 2025 | Viewed by 9

Special Issue Editors


E-Mail Website
Guest Editor
Department of Chemistry, University of Florence, Via Schiff 6, Sesto Fiorentino, 50019 Florence, Italy
Interests: cyclodextrins; drug delivery systems; drug-in-cyclodextrins-in-colloidal systems; microparticulate systems
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Chemistry, University of Florence, Via Schiff 6, Sesto Fiorentino, 50019 Florence, Italy
Interests: cyclodextrins; drug delivery systems; drug-in-cyclodextrin-in-nanolipid carriers; oral administration; pediatric formulations; topical delivery
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Departamento de Ciencias Químicas, Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México, Cuautitlán Izcalli 54740, Mexico
Interests: green chemistry; supramolecular chemistry; materials science; computational chemistry; cyclodextrins; natural products; bioactive compounds and materials

E-Mail Website
Guest Editor
Chemical Sciences Department, Cuautitlan Izcalli 54740, Mexico
Interests: green chemistry; supramolecular chemistry; materials science; computational chemistry; cyclodextrins; natural products; bioactive compounds and materials

Special Issue Information

Dear Colleagues,

Cyclodextrins remain highly relevant in the pharmaceutical field due to their ability to form inclusion complexes with a wide range of drugs. These inclusion complexes modify the physicochemical properties of the drugs, potentially enhancing their therapeutic effects. Furthermore, cyclodextrins and their derivatives address some of the challenges of conventional drug delivery systems by enhancing bioavailability and minimizing toxicity.

In recent years, the use of these oligosaccharides as foundational elements for biomedical materials and nanoparticles has increased, offering new therapeutic alternatives for various conditions. Therefore, it is necessary to compile a collection of works that contribute to the study of cyclodextrins, both theoretically and experimentally.

This Special Issue aims to present new contributions to the study of cyclodextrins in the context of pharmaceutical, pharmacological, and biomedical applications. We welcome both theoretical and experimental articles, as well as comprehensive reviews related to this topic.

Dr. Francesca Maestrelli
Dr. Marzia Cirri
Dr. María Inés Nicolás Vazquez
Dr. René Escobedo-González
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cyclodextrin-based nanoparticles and nanomaterials
  • modified cyclodextrins and pharmaceutical uses
  • drug release systems
  • biomaterials
  • pharmaceutical applications

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop